Rocket Pharmaceuticals (RCKT) Other Non Operating Income (2015)
Rocket Pharmaceuticals (RCKT) posted Other Non Operating Income of $38.4 million for Q4 2015, up 182.3% sequentially from -$46.6 million in Q3 2015.
Analysis
Rocket Pharmaceuticals (RCKT) Other Non Operating Income (2015) Analysis & Trends
Rocket Pharmaceuticals has reported Other Non Operating Income for 1 years, with the latest figure at $38.4 million in Q4 2015.
- Quarterly Other Non Operating Income changed N/A year-over-year to $38.4 million in Q4 2015, while the trailing twelve-month figure through Dec 2015 was -$7.1 million (changed N/A YoY) and the FY2015 annual result came in at -$4.4 million, changed N/A from the prior year.
- Other Non Operating Income grew to $38.4 million in Q4 2015 per RCKT's latest filing, from -$46.6 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $38.4 million in Q4 2015 and troughed at -$46.6 million in Q3 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Rocket Pharmaceuticals | 437.27 Mn | 437.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | -46.65 Mn |
| Jun 30, 2015 | 1.86 Mn |
| Mar 31, 2015 | 2.00 Mn |